ORMP icon

Oramed Pharmaceuticals
ORMP

Overview Fund Trends Analyst Outlook Journalist POV

15 hedge funds and large institutions have $13.6M invested in Oramed Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$12.2M
2
+$798K
3
+$184K
4
HCM
Highlander Capital Management
New Jersey
+$15.4K
5
U
UBS
Switzerland
+$15.1K

Top Sellers

1
-$165K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$12.2M
2
$798K
3
$299K
4
$184K
5
$54K
6
$24K
7
$21K
8
$15.4K
9
$15K
10
$11K
11
$5K
12
$5K
13
$4K
14
$3K
15
–